Add BrightSurf on Google Email

Prozac appears to blunt formation of PTSD symptoms after traumatic injury in small study

A preliminary study found that people taking Prozac after a traumatic injury reported fewer PTSD symptoms and lower pain levels in the year following their injury. The study suggests that preventative medical interventions could reduce the formation of post-traumatic stress disorder symptoms.

SourceUniversity of Florida·JournalJournal of Orthopaedic Trauma·TypeRandomized controlled/clinical trial·DateAug 3, 2026

After anesthesia

Researchers found that female mice's microglia form prolonged contacts with neurons during recovery, leading to synaptic remodeling and plasticity. This phenomenon was not observed in male mice, highlighting differences in brain recovery processes between sexes.

SourceInstitute of Science and Technology Austria·JournalScience Advances·TypeExperimental study·DateJul 31, 2026
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Personalized brain imaging may improve outcomes for treatment-resistant depression

A new study suggests that functional brain imaging can help guide accelerated transcranial magnetic stimulation (TMS) for depression, leading to improved symptoms and response rates. The approach uses resting-state functional connectivity analysis to identify individualized treatment targets.

SourceBrigham and Women's Hospital·JournalJAMA Psychiatry·TypeRandomized controlled/clinical trial·DateJun 24, 2026

Monitoring reveals elevated antidepressant levels in some waterways

Researchers found high levels of antidepressant drugs in four North Carolina rivers, exceeding toxic thresholds for aquatic life. The study highlights the need for effective remediation strategies to mitigate environmental contamination and human health risks.

SourceAmerican Chemical Society·JournalEnvironmental Science & Technology·DateJun 3, 2026

Time for a re-think of long-term antidepressant use

A new summary of evidence reveals that antidepressants have limited benefits beyond 12 months and may cause severe withdrawal symptoms. Researchers are calling for treatment reviews every six months and recommending gradual weaning strategies when discontinuing medication.

SourceAdelaide University·JournalAustralian Journal of General Practice·TypeSystematic review·DateJun 3, 2026
Kestrel 3000 Pocket Weather Meter

Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.

The Lancet Psychiatry: No clear link between common antidepressant use in pregnancy and autism or ADHD in children, finds most comprehensive study to date

A systematic review and meta-analysis published in The Lancet Psychiatry found no clear link between common antidepressant use in pregnancy and increased risk of neurodevelopmental disorders like autism and ADHD in children. However, the study suggests that genetic predisposition and other factors may contribute to an increased risk.

SourceThe Lancet·JournalThe Lancet Psychiatry·TypeMeta-analysis·DateMay 14, 2026

Opioids and other drugs accumulating in freshwater fish

A new study reveals that freshwater fish are accumulating antidepressants, opioids, and other drugs of abuse in their bodies, which can alter their behavior, development, and reproduction. The research uses a novel analytical method to detect these substances in small fish living in rivers receiving urban wastewater.

SourceUniversity of Waterloo·JournalEnvironmental Pollution·TypeExperimental study·DateApr 16, 2026

Antidepressant unable to prevent chemotherapy-associated nerve damage

A randomized trial found that duloxetine does not prevent painful neuropathy caused by oxaliplatin-based chemotherapy in patients with stage II or III colorectal cancer. The study suggests that duloxetine should only be used for managing existing neuropathy, not prevention.

SourceAlliance for Clinical Trials in Oncology·JournalJCO Oncology Advances·TypeRandomized controlled/clinical trial·DateApr 8, 2026

Mirtazapine for methamphetamine use disorder

In this randomized clinical trial, mirtazapine effectively reduced methamphetamine use in adults with methamphetamine use disorder. The study's findings have important implications for the treatment of this condition, which currently lacks approved pharmacotherapies.

SourceJAMA Network·JournalJAMA Psychiatry·DateApr 1, 2026
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

Toward strategies for extending ketamine’s antidepressant effects

Researchers identified NOX-1 as a key molecular target to prolong ketamine's therapeutic benefits. Combining ketamine with NOX-1 inhibitors significantly extended its antidepressant-like effects. K-4, a novel AMPAR modulator, also showed rapid antidepressant effects that persisted for at least 2 weeks.

SourceYCU Advanced Medical Research Center·JournalMolecular Psychiatry·TypeExperimental study·DateMar 30, 2026

New test dissolves threat of fake drugs

Researchers have developed a low-cost fake drug detector that uses an infrared sensor to track pill dissolution rates. The device can identify legitimate medications from counterfeit ones with high accuracy, making it a valuable tool in the fight against global health threats.

SourceUniversity of California - Riverside·JournalAnalytical Chemistry·DateMar 19, 2026

New PET imaging study reveals how ketamine relieves treatment-resistant depression

A new PET imaging study reveals that ketamine relieves treatment-resistant depression by altering AMPAR in brain regions, providing potential biomarker for personalized treatment. The study found that ketamine increased AMPAR density in several cortical regions and decreased it in reward-related areas, strongly correlating with reducti...

SourceYCU Advanced Medical Research Center·JournalMolecular Psychiatry·TypeImaging analysis·DateMar 6, 2026
Apple AirPods Pro (2nd Generation, USB-C)

Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.

“What causes the delay in antidepressant effects? ” DGIST identifies brain neuropeptides as key drivers behind delayed antidepressant effects for the first time

Researchers have identified brain neuropeptides as key drivers behind delayed antidepressant effects for the first time. The study found that medication-driven serotonin levels primarily serve as a 'starting signal' while the peptide plays a central role in brain recovery.

SourceDGIST (Daegu Gyeongbuk Institute of Science and Technology)·JournalMolecular Psychiatry·DateMar 4, 2026

Study: Discontinuing antidepressants in pregnancy nearly doubles risk of mental health emergencies

Patients who stopped taking antidepressant medication during pregnancy had a nearly two-fold higher risk of experiencing mental health emergencies, with peaks in the first and ninth months. Researchers found no difference in prior mental health visits between those who continued or discontinued therapy.

SourceSociety for Maternal-Fetal Medicine·JournalPregnancy·TypeObservational study·DateFeb 11, 2026

The pitfalls of one-size-fits-all AI mental health treatment

A new study from George Mason University reveals that AI-driven antidepressant treatment can be less effective for African American patients due to the use of general population data. The study suggests that incorporating additional patient demographics, such as race and ethnicity, can improve the tool's effectiveness.

SourceGeorge Mason University·JournalJournal of Health Equity·DateFeb 4, 2026

Antidepressants not associated with serious complications from TBI

A study published in Neurology found that taking antidepressants after a traumatic brain injury (TBI) is not associated with an increased risk of death, brain surgery, or longer hospital stays. The study included over 54,000 participants and found that antidepressant users had an 11% lower risk of needing emergency brain surgery.

SourceAmerican Academy of Neurology·JournalNeurology·DateJan 28, 2026
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

One in four older Americans with dementia prescribed risky brain-altering drugs despite safety warnings

Research finds that nearly one in four Medicare beneficiaries with dementia are prescribed potentially harmful medications linked to falls, confusion, and hospitalization. Despite declines in prescribing rates, high levels of inappropriate prescribing persist among older adults with cognitive impairment.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA·TypeData/statistical analysis·DateJan 12, 2026

Exercise to treat depression yields similar results to therapy

A Cochrane review found that exercise can reduce depressive symptoms similarly to psychological therapy, with moderate-certainty evidence from ten trials. Long-term effects are unclear due to few studies following participants after treatment.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateJan 7, 2026

The Lancet Psychiatry: Slow tapering plus therapy most effective strategy for stopping antidepressants, finds major meta-analysis

A systematic review and network meta-analysis of 76 randomised controlled trials found that slow tapering of antidepressants combined with psychological support prevented relapse over the following year to a similar extent as remaining on an antidepressant. This approach could change how coming off antidepressants is managed globally.

SourceThe Lancet·JournalThe Lancet Psychiatry·TypeMeta-analysis·DateDec 10, 2025
Sky-Watcher EQ6-R Pro Equatorial Mount

Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.

Research spotlight: A subset of patients with depression could benefit from anti-inflammatory treatment

A subset of depressed individuals with chronic, low-grade inflammation may benefit from anti-inflammatory treatment, according to a systematic review and meta-analysis. The study found that anti-inflammatory medications significantly reduced depressive symptom severity and anhedonia in these patients.

SourceBrigham and Women's Hospital·JournalAmerican Journal of Psychiatry·TypeSystematic review·DateDec 10, 2025

Long-term antidepressant use surges in Australia, sparking warnings of overprescribing

A new study found that long-term antidepressant use has increased by nearly 20% among young people aged 10-24, raising concerns about potential overprescribing. The study also found no meaningful improvement in efforts to wean patients off antidepressants, highlighting the need for a stronger framework for safely tapering medications.

SourceUniversity of South Australia·JournalPharmacoepidemiology and Drug Safety·TypeData/statistical analysis·DateDec 2, 2025

New molecule reduces ethanol intake and drinking motivation in mice, with sex-dependent differences

A new compound MCH11, a monoacylglycerol lipase inhibitor, shows promising effects in reducing alcohol consumption and motivation to drink in mice. The molecule exhibits anxiolytic and antidepressant properties with sex-dependent efficacy, correcting genetic alterations associated with alcohol use disorder.

SourceUniversidad Miguel Hernandez de Elche·JournalBiomedicine & Pharmacotherapy·TypeExperimental study·DateNov 11, 2025
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Adenosine is the metabolic common pathway of rapid antidepressant action: The coffee paradox

A recent landmark study identifies adenosine as the critical mediator of rapid antidepressant action, connecting ketamine, ECT, and hypoxia. The discovery raises questions about the potential interference of caffeine with these treatments, highlighting the need for further research on adenosinergic modulation in depression.

SourceGenomic Press·JournalBrain Medicine·TypeLiterature review·DateNov 11, 2025

Antidepressants improve core depressive symptoms early on

A new analysis of the PANDA trial found that sertraline contributes to improvements in low mood and suicidal thinking within two weeks of taking the drug. The study also revealed an improvement in emotional symptoms of depression within two weeks, with continued benefits from six weeks to 12 weeks.

SourceUniversity College London·JournalNature Mental Health·TypeRandomized controlled/clinical trial·DateOct 30, 2025

Yueju Pill or escitalopram in MDD?

A randomized, double-blind trial compared Yueju Pill and escitalopram in treating major depressive disorder (MDD). The study found that Yueju Pill improved depression symptoms and increased serum brain-derived neurotrophic factor (BDNF) levels. Brain network patterns were also predictive of treatment response in the Yueju Pill group.

SourceShanghai Jiao Tong University Journal Center·JournalGeneral Psychiatry·TypeExperimental study·DateOct 24, 2025
Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

GQ GMC-500Plus Geiger Counter

GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.

Treatment timing is critical to Prozac's impact on mood behaviors

Researchers found that Prozac's impact on mood behaviors is critical to the timing of its administration, with early postnatal exposure leading to increased anxiety- and depression-like behaviors, while adolescent exposure had the opposite effect. This study provides crucial mechanistic insights into alterations in neurocircuits that r...

SourceElsevier·JournalBiological Psychiatry·TypeExperimental study·DateJul 7, 2025
Fluke 87V Industrial Digital Multimeter

Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.

Antidepressant use in teens contributes to increased pain sensitivity in adulthood

A new study from the University of Texas at El Paso finds that adolescent antidepressant use, particularly Prozac, may contribute to increased pain sensitivity in adulthood. The research suggests that early exposure to these medications can disrupt brain development and increase inflammatory markers, leading to heightened pain perception.

SourceUniversity of Texas at El Paso·JournalJournal of Psychiatric Research·DateMay 27, 2025

Common antidepressants could help the immune system fight cancer, UCLA study finds

A UCLA study found that selective serotonin reuptake inhibitors (SSRIs) can significantly enhance the ability of T cells to fight cancer and suppress tumor growth across various cancer types in mouse and human tumor models. SSRIs increased access to serotonin signals, making killer T cells happier and more effective at killing cancer c...

SourceUniversity of California - Los Angeles Health Sciences·JournalCell·DateMay 21, 2025

Antidepressant withdrawal symptoms more common among long-term users

A new study found that people taking antidepressants for over two years are more likely to experience withdrawal symptoms, including anxiety and fatigue. Long-term users also tend to have worse withdrawal symptoms and are less able to stop taking the medication.

SourceUniversity College London·JournalPsychiatry Research·TypeSurvey·DateMay 21, 2025
DJI Air 3 (RC-N2)

DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.

Study finds brain-based markers could help personalize depression treatment

A new study reveals promising progress toward predicting how patients with major depressive disorder will respond to antidepressant medications. Brain connectivity patterns were found to significantly improve predictions of treatment response across two large, independent clinical trials.

SourceCentre for Addiction and Mental Health·JournalJAMA Network Open·DateApr 23, 2025

A depression treatment that starts with understanding yourself and others

A recent study suggests dynamic interpersonal therapy (DIT) can help alleviate depressive symptoms by enhancing mentalising capacity. Patients receiving DIT combined with medication showed significantly greater improvement in depressive symptoms and mentalising ability.

SourceShanghai Jiao Tong University Journal Center·JournalGeneral Psychiatry·TypeNews article·DateMar 31, 2025

Nearly half of depression diagnoses could be considered treatment-resistant

A new study suggests that nearly half of depression diagnoses could be considered treatment-resistant, with 48% of patients trying at least two antidepressants and 37% trying four or more. This highlights the need for better treatment options to support patients who don't respond to first-line medications.

SourceUniversity of Birmingham·JournalThe British Journal of Psychiatry·TypeData/statistical analysis·DateMar 21, 2025
Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

New artificial intelligence tool accelerates disease treatments

Researchers at the University of Virginia Health System have developed a computational tool called LogiRx that can predict how drugs will affect biological processes in the body. The tool has demonstrated its potential by identifying a promising candidate to prevent heart failure, a leading cause of death worldwide.

SourceUniversity of Virginia Health System·JournalProceedings of the National Academy of Sciences·DateMar 18, 2025

Demonstrates the relationship between antidepressants and weight gain

A recent study published in Frontiers in Psychiatry reveals a strong link between antidepressant use and weight gain, with an average 2% increase in body weight among participants. The study highlights the need to consider this association when prescribing antidepressants and monitor weight changes accordingly.

SourceIMIM (Hospital del Mar Medical Research Institute)·JournalFrontiers in Psychiatry·DateFeb 26, 2025

Antidepressants linked to faster cognitive decline in dementia

A new observational study suggests that antidepressants can accelerate cognitive decline in people with dementia, while certain medications appear to be less harmful. Researchers analyzed data from 18,740 patients and found that selective serotonin reuptake inhibitors (SSRIs) were associated with the fastest cognitive decline.

SourceKarolinska Institutet·JournalBMC Medicine·TypeObservational study·DateFeb 24, 2025

The role of ketamine in treatment-resistant depression

Ketamine has been shown to rapidly reduce depressive symptoms in patients with treatment-resistant depression, often within hours of administration. However, the long-term efficacy and safety of ketamine therapy remain uncertain, with potential risks including cognitive impairment and cardiovascular effects.

SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateFeb 19, 2025
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

Ketamine: From club drug to antidepressant?

Researchers have uncovered ketamine's mechanism of action, revealing how it affects the brain's NMDA receptors. The study provides hope for synthesizing new versions of the drug with fewer harmful side effects.

SourceCold Spring Harbor Laboratory·JournalNeuron·DateFeb 14, 2025

Antidepressant use before, during, and after pregnancy

The study found a significant decrease in antidepressant use during pregnancy without an accompanying increase in psychotherapy. This suggests that pregnant women with depression or anxiety may be able to effectively manage their symptoms with medication alone.

SourceJAMA Network·JournalJAMA Network Open·DateJan 30, 2025
Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

Delayed REM sleep could be an early sign of Alzheimer’s

A study found that people with delayed REM sleep have higher levels of toxic proteins amyloid and tau, and lower levels of healthy protein BDNF, which can increase the risk of developing Alzheimer's. Practicing healthy sleep habits may help mitigate this risk.

SourceUniversity of California - San Francisco·DateJan 27, 2025

Insurance coverage, type of employment shape inequities in access to semaglutide

A new study found disparities in access to semaglutide based on insurance plan, job industry, sex, and other factors. Individuals with female identities, preferred provider organization coverage, and antidepressant use were more likely to start taking semaglutide compared to males or those with certain employment industries.

SourceBoston University School of Public Health·JournalJAMA Network Open·TypeObservational study·DateJan 22, 2025

Scientists uncover rapid-acting, low-side-effect antidepressant target

A new study reveals that delta opioid receptor agonist KNT-127 has a rapid and effective antidepressant effect with minimal side effects. The research highlights the molecular mechanisms underlying its action, including mTOR signaling pathways and Akt activation in the medial prefrontal cortex.

SourceTokyo University of Science·JournalMolecular Psychiatry·TypeExperimental study·DateJan 14, 2025

Commonly prescribed medications increase fall risk and related injuries in people with COPD

A new study published in the COPD Foundation journal found that people with chronic obstructive pulmonary disease (COPD) are at a higher risk of falls and related injuries when taking commonly prescribed medications. The likelihood of falls increases relative to the number of fall-risk increasing drugs used.

SourceCOPD Foundation·JournalChronic Obstructive Pulmonary Diseases Journal of the COPD Foundation·DateJan 14, 2025
Nikon Monarch 5 8x42 Binoculars

Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.